• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Winter Is Coming! Clinical, Immunologic, and Practical Considerations for Vaccinating Patients With Inflammatory Bowel Disease During the Coronavirus Disease-2019 Pandemic
As summer turns to fall, clinicians' minds usually turn to the upcoming winter season and preparing for winter infections, particularly influenza. In 2020, though, we face a new and formidable foe: the severe acute respiratory syndrome novel coronavirus-2 (SARS-CoV-2). Although we hope that an effective vaccine against SARS-CoV-2 will soon be available, the distribution of an effective vaccine is not likely to occur soon, so it is especially appropriate to use the other tools already at our disposal to keep our patients with inflammatory bowel disease (IBD) well.
Source: Gastroenterology - October 13, 2020 Category: Gastroenterology Authors: Gil Y. Melmed, David T. Rubin, Dermot P.B. McGovern Tags: Commentary Source Type: research

Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus.
Authors: Di Pierro F, Bertuccioli A, Cavecchia I Abstract The outbreak of SARS-CoV-2 disease (COVID-19) is currently, March 2020, affecting more than 100000 people worldwide and, according to the WHO (World Health Organization), a pandemic is shortly expected. The virus infects the lower respiratory tract and causes severe pneumonia and mortality in approximately 10% and 3-5%, respectively, of cases, mainly among the elderly and/or people affected by other diseases. AHCC is an α-glucan-based standardized mushroom extract that has been extensively investigated as an immunostimulant both in animals and/or in humans ...
Source: Minerva Gastroenterologica e Dietologica - March 14, 2020 Category: Gastroenterology Tags: Minerva Gastroenterol Dietol Source Type: research